NL-OMON43548
Completed
Phase 2
Improved screening of esophageal cancer by optical detection of field cancerization. - SPECTRE
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- 1. Malignant cells in Barretts esophagus. 2. Field carcinogenesis.
- Sponsor
- Academisch Medisch Centrum
- Enrollment
- 60
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •\- Patients referred for endoscopic treatment of early neoplasia in a Barrett\*s esophagus or patients undergoing standard endoscopic surveillance for non\-dysplastic Barrett\*s esophagus.
- •\- Age \> 18 years.
- •\- Signed informed consent.
Exclusion Criteria
- •\- Contraindications for ER and/or obtain biopsies (e.g. due to anticoagulation, coagulation disorders, esophageal varices).
- •\- Presence of an advanced lesion (e.g. type 0\-I or type 0\-III) not amendable for endoscopic resection (T1b).
- •\- Presence of erosive esophagitis (Los Angeles classification \>\=A).
- •\- Unable to provide signed informed consent.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
SPECTRE-studyBarrett's esophagus, esophageal cancer, field cancerizationNL-OMON21436Academic Medical Center (AMC) Amsterdam60
Active, not recruiting
Phase 1
Detection of early stages of esophageal cancer with fluorescence molecular endoscopy.Patients with Barretts esophagus and there is a suspicion for at least low grade dysplasia.Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2018-004745-17-NLniversity Medical Center Groningen60
Recruiting
Not Applicable
Surveillance for esophageal cancer using NBI endoscopySuperficial esophageal squamous cell carcinomaJPRN-UMIN000013700Osaka City University Graduate School of Medicine100
Recruiting
Not Applicable
Investigation of the esophageal lesions using endocytoscopy systemesophageal lesionsJPRN-UMIN000007627Saitama Medical Center, Saitama Medical University80
Recruiting
Not Applicable
functional esophageal-and gastric-cancer screeningStomach, unspecifiedC15.9C16.9Oesophagus, unspecifiedDRKS00005037Institut für Kreislaufforschung und SportmedizinAbteilung molekulare und zelluläre Sportmedizin180